VanEck Associates’s Legence Corp LGN Stock Holding History

VanEck Associates’s Portfolio LGN Stock Details LGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,889	Closed	-$615K	–	1503
2026 Q1	$615K	Buy	10,889 +1,889	+21%	+$95.2K	﹤0.01%	1154
2025 Q4	$387K	Buy	+9,000	New	+$356K	﹤0.01%	1216

Other funds holding LGN

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FACM

Forest Avenue Capital Management Miami, Florida $2.38B AUM 88.67% 1-Year Est. Return

VanEck Associates's LGN Position: Q2 2026 in Review

VanEck Associates sold out of Legence Corp (LGN) in Q2 2026, closing a stake of 10,889 shares — an estimated $615K sold.

VanEck Associates first reported a position in LGN in Q4 2025 and held it in 2 quarters. The position peaked at $615K in Q1 2026. 267 funds tracked by Wall St. Rank hold LGN as of Q2 2026.

VanEck Associates reported no remaining Legence Corp position as of Q2 2026 after selling out during the quarter.
VanEck Associates sold 10,889 Legence Corp shares in Q2 2026, an estimated $615K.
VanEck Associates first reported a position in Legence Corp in Q4 2025 and held it in 2 quarters.
VanEck Associates's Legence Corp position peaked at $615K in Q1 2026.
267 funds tracked by Wall St. Rank held Legence Corp as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.